Adaptive Biotechnologies Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adaptive Biotechnologies Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q3 2024.
  • Adaptive Biotechnologies Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $46.5M, a 38.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $46.5M -$28.7M -38.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $48.5M -$28.6M -37.1% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $51M -$28M -35.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $52.1M -$28.7M -35.5% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $75.3M -$7.34M -8.89% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $77.1M -$7.29M -8.64% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $79M -$6.67M -7.79% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $80.8M -$6.92M -7.89% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $82.6M -$6.84M -7.65% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $84.4M -$7.67M -8.33% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $85.6M -$2.87M -3.24% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $87.7M -$11.7M -11.7% Dec 31, 2021 10-K 2023-02-14
Q3 2021 $89.4M +$51.7M +137% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $92.1M +$54.4M +145% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $88.5M +$57.4M +185% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $99.4M Dec 31, 2020 10-K 2022-02-15
Q3 2020 $37.7M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $37.6M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $31.1M Mar 31, 2020 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.